← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 30, 2020Last known activity
Dec 12, 2024
Timeline
2010s
- Jan 1, 2013
Arcturus Therapeutics— Founded
- Nov 16, 2017
Alcobra Ltd.— Acquired
Drugs by trial phase (9 distinct, 21 trials)
Phase 3 (1 own, 1 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (18)
- NCT06602531OfficialPhase 1Dec 12, 2024
- NCT06602531Lead sponsorPhase 1Dec 12, 2024
- NCT06747858Lead sponsorPhase 2Dec 12, 2024
- NCT06488313Lead sponsorPhase 2Jun 10, 2024
- NCT06125691Lead sponsorPhase 1Dec 31, 2023
- NCT06125691Study directorPhase 1Dec 31, 2023
- NCT05712538OfficialPhase 1Feb 15, 2023
- NCT05712538Study directorPhase 1Feb 15, 2023
- NCT05712538Lead sponsorPhase 1Feb 15, 2023
- NCT05526066Lead sponsorPhase 2Jul 6, 2022
- NCT05037097Lead sponsorPhase 1/Phase 2Aug 30, 2021
- NCT05012943CollaboratorPhase 2/Phase 3Aug 15, 2021
- NCT05012943Lead sponsorPhase 2/Phase 3Aug 15, 2021
- NCT04728347Lead sponsorPhase 2Jan 4, 2021
- NCT04668339Lead sponsorPhase 2Dec 27, 2020
Details
- Founded
- San Diego, CA, US Jan 1, 2013
- Last known activity
- Dec 12, 2024